Brief: Oragenics Announces Leadership Transition
12/02/2024 22:49
Feb 12 (Reuters) - Oragenics Inc OGEN.A :
* ORAGENICS, INC. ANNOUNCES LEADERSHIP TRANSITION
* ORAGENICS INC - KIMBERLY MURPHY, COMPANY'S CHIEF EXECUTIVE
OFFICER, ENTERED INTO A MUTUALLY AGREEABLE SEPARATION AGREEMENT
* ORAGENICS INC - CHARLIE POPE SERVING, ON AN INTERIM
BASIS, AS
EXECUTIVE CHAIRMAN
* ORAGENICS INC - PURSUANT TO AGREEMENT MURPHY'S EMPLOYMENT
WITH
COMPANY TERMINATED EFFECTIVE FEBRUARY 12, 2024.
* ORAGENICS INC: EFFECTIVE FEB 12, BOARD APPOINTED MICHAEL
REDMOND, CO'S PRESIDENT, AS INTERIM PRINCIPAL EXECUTIVE OFFICER
Source text for Eikon: ID:nBwyBrmka
Further company coverage: OGEN.A
((reuters.briefs@thomsonreuters.com;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing